نتایج جستجو برای: غشای زیولیتی naa

تعداد نتایج: 5554  

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه صنعتی اصفهان - دانشکده مهندسی شیمی 1389

فرآیند تراوش تبخیری یکی از انواع فرآیندهای جداسازی غشایی است که در سال های اخیر در جداسازی مخلوط مایعات بسیار مورد بررسی قرارگرفته است. اغلب غشاهای مورد استفاده در این فرآیند از نوع غشاهای پلیمری می باشند اما در سال های اخیر علاقه خاصی به استفاده از غشاهای غیرپلیمری به ویژه غشاهای زئولیتی ایجاد شده است. این امر بیشتر به دلیل خصوصیات منحصر به فرد زئولیت ها از جمله داشتن منافذی با ابعاد مولکولی و...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه اراک - دانشکده فنی 1393

کم آبی و خشکسالی های متوالی باعث گشته که اکثر نقاط جهان در حال حاضر با خطرات خشکی روبرو گردد. جهت استفاده بهینه از منـابع آبـی در دسترس، لازم است برنامه ریزی مناسبی را ارائه داد. در جهت افزایش میزان کارایی آب از مواد مختلفی استفاده مـی شـود، یکی از ایـن مـواد پلیمرهـای سوپرجاذب بوده که در سطح وسیعی در جهان مورد استفاده قرار میگیرند. این مواد ضمن قرار گرفتن در خاک و جذب آب ثقلی و غیر قابل استفاد...

2006
Mattias Tranberg

N-acetylaspartate (NAA) is an amino acid derivative present in high concentration in the brain. The function of NAA is still unsettled in spite of 50 years of research. The mainly neuronal synthesis and glial breakdown of NAA requires a well regulated neuronal efflux and glial uptake. In the present work hippocampal slices were used to study how NAA efflux from neurons is regulated and to furth...

Journal: :Journal of neurochemistry 2004
In-Young Choi Rolf Gruetter

The rate of (13)C-label incorporation into both aspartyl (NAA C3) and acetyl (NAA C6) groups of N-acetyl aspartate (NAA) was simultaneously measured in the rat brain in vivo for up to 19 h of [1-(13)C]glucose infusion (n = 8). Label incorporation was detected in NAA C6 approximately 1.5 h earlier than in NAA C3 because of the delayed labeling of the precursor of NAA C3, aspartate, compared to t...

2016
Liqin Hu Min Li Wenshang Hou Jingran Zhou Xiaowei Zhang Baoping Yang Yuan Tan Jiang tao Huang Zhenyu Tang

Objective: Alzheimer’s disease (AD) is a neural degenerative disease with progressive cognitive impairment. N-acetyl aspartic acid (NAA) is an important biomarker for assessing neuronal activity and brain cells metabolic abnormalities. This investigation is aimed to establish a liquid chromatography-mass spectrometry (LC-MS) method for measuring plasma NAA level, in order to make clear whether ...

2010
Eva Kolwijck Ron A. Wevers Udo F. Engelke Jannes Woudenberg Johan Bulten Henk J. Blom Leon F. A. G. Massuger

BACKGROUND In humans, N-acetyl L-aspartate (NAA) has not been detected in other tissues than the brain. The physiological function of NAA is yet undefined. Recently, it has been suggested that NAA may function as a molecular water pump, responsible for the removal of large amounts of water from the human brain. Ovarian tumors typically present as large cystic masses with considerable fluid accu...

2017
Juliane G. Bogner-Strauss

N-acetylaspartate (NAA) is a highly abundant brain metabolite. Aberrant NAA concentrations have been detected in many pathological conditions and although the function of NAA has been extensively investigated in the brain it is still controversial. Only recently, a role of NAA has been reported outside the brain. In brown adipocytes, which show high expression of the NAA-producing and the NAA-c...

Journal: :Archives of neurology 2006
Sanjay Kalra Christopher C Hanstock W R Wayne Martin Peter S Allen Wendy S Johnston

BACKGROUND Clinical assessment is insensitive to the degree of cerebral involvement in amyotrophic lateral sclerosis (ALS). Regional brain concentrations N-acetylaspartylglutamate (NAA) plus myo-inositol (Ins), as measured by magnetic resonance spectroscopy, are respectively decreased and increased, suggesting that these compounds may provide a biomarker of the degree of cerebral involvement in...

2015
Xiaofen Zong Maolin Hu Zongchang Li Hongbao Cao Ying He Yanhui Liao Jun Zhou Deen Sang Hongzeng Zhao Jinsong Tang Luxian Lv Xiaogang Chen

It is unclear whether N-acetylaspartate (NAA) depletions documented in schizophrenia patients might be due to the disease progression or medications. Here we investigated longitudinal NAA changes in drug-naïve first-episode patients (FEP) who are relatively free from chronicity. Forty-two drug-naïve FEP and 38 controls were enrolled in this study to explore the effect of 8-week risperidone mono...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید